Nvidia reports better-than-expected fourth-quarter earnings as revenue jumps 78% on demand for the company’s ...

The Trump administration is reviewing a contract extended to Moderna in the final days of the Biden administration.

American pharmaceutical company Moderna (MRNA) is reportedly under scrutiny by U.S. President Donald Trump’s team, which is ...

Moderna Inc.'s stock tumbled 4% Thursday, after a report that health officials are reviewing a contract the company won from the Biden administration to support its efforts to develop a bird-flu ...

U.S. health officials are reevaluating a $590M bird flu vaccine contract that was awarded to Moderna ( NASDAQ: MRNA) by the ...

Moderna's reliance on its COVID vaccine for revenue has become a vulnerability as sales decline and the company invests heavily in its product pipeline. The bird flu vaccine contract was expedited due ...

US health officials are reevaluating a $590 million contract for bird flu shots that the Biden administration awarded to ...

Health-care company stocks declined. Moderna shares fell after reports that federal health officials are re-evaluating its $590 million contract to help develop a bird-flu vaccine. Shares of Teladoc ...

While the details surrounding the new virus are still unfolding, the market's reaction reflects concern over the potential ...

The bird flu shot contract was awarded to Moderna in the Biden administration's final days, sending the company's stock up 13 ...

Concerns about coronavirus news out of China may have moved some vaccine-maker and travel stocks Friday.